These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17378699)

  • 1. Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program.
    Chao SH; Urbano FL
    J Manag Care Pharm; 2007 Jan; 13(1 Suppl):S3-6. PubMed ID: 17378699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative safety and effectiveness of TNF-alpha antagonists [corrected].
    Solomon DH
    J Manag Care Pharm; 2007 Jan; 13(1 Suppl):S7-18. PubMed ID: 17378700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AHRQ's Effective Health Care Program: its impact on managed care.
    Fleming WK
    J Manag Care Pharm; 2007 Jan; 13(1 Suppl):S19-20. PubMed ID: 17378701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.
    Singh JA; Cameron DR
    J Manag Care Pharm; 2012 May; 18(4 Supp C):S1-18. PubMed ID: 22656072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular medicine, the Medicare drug benefit, and the need for cost control.
    Gillick MR
    J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.
    Doan QV; Chiou CF; Dubois RW
    J Manag Care Pharm; 2006 Sep; 12(7):555-69. PubMed ID: 16981801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; e-prescribing and the prescription drug program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Nov; 70(214):67567-95. PubMed ID: 16273748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From research to nationwide implementation: the impact of AHRQ's HAI prevention program.
    Battles JB; Farr SL; Weinberg DA
    Med Care; 2014 Feb; 52(2 Suppl 1):S91-6. PubMed ID: 24430273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medicare Prescription Drug Improvement and Modernization Act: prescription drugs and academic medicine.
    Frencher SK; Glied S
    Acad Med; 2006 Sep; 81(9):812-6. PubMed ID: 16936488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare program; establishment of the Medicare advantage program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4587-741. PubMed ID: 15678604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the impacts of the Medicare Modernization Act: concerns of congressional staff.
    Mueller KJ; Coburn AF; MacKinney AC; McBride TD; Slifkin RT; Wakefield MK
    J Rural Health; 2005; 21(3):194-7. PubMed ID: 16092291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.